Source link : https://www.newshealth.biz/health-news/common-heart-failure-drugs-ease-heart-damage-during-chemo/
Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized controlled study of this approach. The small, double-blind, placebo-controlled study, called SARAH, involved 114 patients in Brazil and was conducted over 6 months. It targeted patients undergoing chemotherapy […]
Author : News Health
Publish date : 2024-11-19 06:35:34
Copyright for syndicated content belongs to the linked Source.
inHealth